Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement.
Abstract
DESCRIPTION: Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for and treatment of hepatitis C virus (HCV) infection in asymptomatic adults. METHODS: The Agency for Healthcare Research and Quality commissioned 2 systematic reviews on screening for and treatment of HCV infection in asymptomatic adults, focusing on evidence gaps identified in the previous USPSTF recommendation and new studies published since 2004. The evidence on screening for HCV in pregnant women was also considered. POPULATION: This recommendation applies to all asymptomatic adults without known liver disease or functional abnormalities. RECOMMENDATION: The USPSTF recommends screening for HCV infection in persons at high risk for infection. The USPSTF also recommends offering 1-time screening for HCV infection to adults born between 1945 and 1965. (B recommendation).
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The most important risk factor for HCV infection is past or current injecting drug use.
“The most important risk factor for HCV infection is past or current injecting drug use (157).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [157]
Cites
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2008) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,971 · see citing works
van der Meer, A. J., Veldt, B. J., Feld, J. J., Wedemeyer, H. H., Dufour, J., Lammert, F., Duarte‐Rojo, A., Heathcote, E. J., Manns, M. P., Kuske, L., et al. (2012) · JAMA · doi:10.1001/jama.2012.144878 · Cited by 1,507 · see citing works
(U.S.), C. F. D. C. A. P. (1998) · PsycEXTRA Dataset · doi:10.1037/e547602006-001 · Cited by 1,213 · see citing works
Smith, B. D., Morgan, R. L., Beckett, G. A., Falck-Ytter, Y. T., Holtzman, D. J., Teo, C., Jewett, A., Baack, B. N., Rein, D. B., Patel, N., et al. (2012) · PubMed · Cited by 991 · see citing works
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
Morgan, R. L., Baack, B. N., Smith, B. D., Yartel, A. K., Pitasi, M. A., & Falck-Ytter, Y. T. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-5-201303050-00005 · Cited by 830 · see citing works
A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C
Backus, L. I., Boothroyd, D. B., Phillips, B. R., Belperio, P. S., Halloran, J. P., & Mole, L. A. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.004 · Cited by 480 · see citing works
Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
Chou, R., & Wasson, N. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-11-201306040-00005 · Cited by 369 · see citing works
Rein, D. B., Smith, B. D., Wittenborn, J. S., Lesesne, S. B., Wagner, L. D., Roblin, D. W., Patel, N., Ward, J. W., & Weinbaum, C. M. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-4-201202210-00378 · Cited by 302 · see citing works
American Gastroenterological Association Medical Position Statement on the Management of Hepatitis C
Dienstag, J. L., & McHutchison, J. G. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.011 · Cited by 225 · see citing works
Three Broad Modalities in the Natural History of Vertically Acquired Hepatitis C Virus Infection
The European Paediatric Hepatitis C Virus Network (2005) · Clinical Infectious Diseases · doi:10.1086/430601 · Cited by 193 · see citing works
Myers, R. P., Ratziu, V., Imbert‐Bismut, F., Charlotte, F., & Poynard, T. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05997.x · Cited by 88 · see citing works
Liu, S., Cipriano, L. E., Holodniy, M., & Goldhaber‐Fiebert, J. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058975 · Cited by 68 · see citing works
Screening for Hepatitis C Virus Infection in Adults: Recommendation Statement
U.S. Preventive Services Task Force* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-6-200403160-00013 · Cited by 49 · see citing works
Kimer, N., Dahl, E., Gluud, L. L., & Krag, A. A. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001313 · Cited by 33 · see citing works
The hepatitis C self‐management programme: a randomized controlled trial
Groessl, E. J., Weingart, K. R., Stepnowsky, C. J., Gifford, A. L., Asch, S. M., & Ho, S. B. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01328.x · Cited by 25 · see citing works
Screening for Hepatitis C Virus Infection in Adults
Chou, R., Cottrell, E. B., Wasson, N., Rahman, B., & Guise, J. (2012) · Europe PMC (PubMed Central) · Cited by 21 · see citing works
Treatment for Hepatitis C Virus Infection in Adults
Chou, R., Hartung, D. M., Rahman, B., Wasson, N., Cottrell, E., & Fu, R. (2012) · Europe PMC (PubMed Central) · Cited by 8 · see citing works
Flagged first, then by citations
1 of the 18 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160 · see citing works
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,632 · see citing works
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 2,759 · see citing works
Sexually Transmitted Diseases Treatment Guidelines, 2010
Workowski, K., & BOLAN, G. A. (2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.04.006 · Cited by 2,074 · see citing works
Panel, A. I. H. G. (2015) · Hepatology · doi:10.1002/hep.27950 · Cited by 1,385 · see citing works
Ghany, M. G., Morgan, T. R. M., & Panel, A. H. C. G. (2019) · Hepatology · doi:10.1002/hep.31060 · Cited by 956 · see citing works
Ryerson, A. B., Eheman, C. R., Altekruse, S. F., Ward, J. W., Jemal, A., Sherman, R., Henley, S. J., Holtzman, D. J., Lake, A., Noone, A., et al. (2016) · Cancer · doi:10.1002/cncr.29936 · Cited by 944 · see citing works
White, M. C., Holman, D. M., Boehm, J. E., Peipins, L. A., Grossman, M., & Jane Henley, S. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.10.029 · Cited by 762 · see citing works
CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020
Schillie, S. F., Wester, C., Osborne, M. C., Wesolowski, L. G., & Ryerson, A. B. (2020) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr6902a1 · Cited by 565 · see citing works
Suryaprasad, A. G., White, J. Z., Xu, F., Eichler, B. A., Hamilton, J. J., Patel, A. S., Hamdounia, S. B., Church, D., Barton, K., Fisher, C., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu643 · Cited by 500 · see citing works
Cancer statistics for Hispanics/Latinos, 2015
Siegel, R. L., Fedewa, S. A., Miller, K. D., Sauer, A. G., Pinheiro, P. S., Martinez‐Tyson, D., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21314 · Cited by 467 · see citing works
Yehia, B. R., Schranz, A. J., Umscheid, C. A., & Re, V. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101554 · Cited by 441 · see citing works
“In addition, the proposed HCV treatment cascade provides a framework for evaluating the delivery of HCV care over time and within subgroups, which will be necessary to monitor the impact of new screening efforts [33,34] and advances in antiviral therapy [34,35] which will likely increase the number of people completin…”
BackgroundOutness, Stigma, and Primary Health Care Utilization among Rural LGBT Populations
Whitehead, J. L., Shaver, J., & Stephenson, R. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146139 · Cited by 410 · see citing works
Screening for Hepatitis C Virus Infection in Adolescents and Adults
US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M. D., Caughey, A. B., Donahue, K. E., Doubeni, C. A., Epling, J. W., et al. (2020) · JAMA · doi:10.1001/jama.2020.1123 · Cited by 306 · see citing works
ACG Clinical Guideline: Liver Disease and Pregnancy
Tran, T. T., Ahn, J. C., & Reau, N. S. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.430 · Cited by 305 · see citing works
Link, J. O., Taylor, J. G., Xu, L., Mitchell, M. L., Guo, H., Liu, H., Kato, D., Kirschberg, T. A., Sun, J., Squires, N., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401499g · Cited by 300 · see citing works
van der Meer, A. J., Feld, J. J., Hofer, H., Almasio, P. L., Calvaruso, V., Fernández‐Rodríguez, C., Aleman, S., Ganne‐Carrié, N., D’Ambrosio, R., Pol, S., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.10.017 · Cited by 275 · see citing works
Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023
Conners, E. E., Panagiotakopoulos, L., Hofmeister, M. G., Spradling, P. R., Hagan, L. M., Harris, A. M., Rogers-Brown, J. S., Wester, C. W., Nelson, N. P., Contributors, et al. (2023) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr7201a1 · Cited by 277 · see citing works
Lui, G. K., Saidi, A. S., Bhatt, A. B., Burchill, L. J., Deen, J. F., Earing, M. G., Gewitz, M. H., Ginns, J. N., Kay, J. D., Kim, Y. Y., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000535 · Cited by 236 · see citing works
US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Donahue, K., Doubeni, C. A., Epling, J. W., et al. (2020) · JAMA · doi:10.1001/jama.2020.22980 · Cited by 212 · see citing works
(2018) · Kidney International Supplements · doi:10.1016/j.kisu.2018.06.001 · Cited by 174 · see citing works
“Screening of maintenance hemodialysis patients for HCV infection is recommended by the United States (US) Centers for Disease Control and Prevention (CDC) and also the US Preventive Services Task Force.23,24 Goals of screening in this patient population include early detection of HCV infection, treatment of infection,…”
BackgroundPrevention of Hepatitis C by Screening and Treatment in U.S. Prisons
He, T., Li, K., Roberts, M. S., Spaulding, A. C., Ayer, T., Grefenstette, J. J., & Chhatwal, J. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0617 · Cited by 168 · see citing works
Sauer, A. G., Siegel, R. L., Jemal, A., & Fedewa, S. A. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-1169 · Cited by 169 · see citing works
Ditah, I. C., Ditah, F. A., Devaki, P., Ewelukwa, O., Ditah, C. M., Njei, B. M., Luma, H. N., & Charlton, M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.014 · Cited by 167 · see citing works
“The Centers for Disease Control and US Preventive Services Task Force recommend HCV screening in people born between 1945 and 1965, which corresponds to persons aged 48 to 68 years in 2013 [11,23].”
BackgroundRein, D. B., Wittenborn, J. S., Smith, B. D., Liffmann, D. K., & Ward, J. W. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ220 · Cited by 152 · see citing works
“[1-3] In 2013, this recommendation was affirmed by the United States Preventive Services Task Force (USPSTF) citing the large health benefits of birthcohort testing predicted by modeling studies.”
Hepatitis C Disease Burden in the United States in the era of oral direct‐acting antivirals
Chhatwal, J., Wang, X., Ayer, T., Kabiri, M., Chung, R. T., Hur, C., Donohue, J. M., Roberts, M. S., & Kanwal, F. (2016) · Hepatology · doi:10.1002/hep.28571 · Cited by 149 · see citing works
Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services, 2020
Barrow, R. Y., Ahmed, F., BOLAN, G. A., & Workowski, K. (2020) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr6805a1 · Cited by 144 · see citing works
The Changing Burden of Hepatitis C Virus Infection in the United States: Model-Based Predictions
Kabiri, M., Jazwinski, A. B., Roberts, M. S., Schaefer, A. J., & Chhatwal, J. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0095 · Cited by 138 · see citing works
Sauer, A. G., Siegel, R. L., Jemal, A., & Fedewa, S. A. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0219 · Cited by 123 · see citing works
Younossi, Z. M., Singer, M. E., Mir, H. M., Henry, L. L., & Hunt, S. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.009 · Cited by 122 · see citing works
What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats
Ward, J. W., & Hinman, A. R. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.10.048 · Cited by 119 · see citing works
Smith, A. D., Branch, C. R., Zand, K. A., Subramony, C., Zhang, H., Thaggard, K., Hosch, R., Bryan, J. A., Vasanji, A., Griswold, M. E., et al. (2016) · Radiology · doi:10.1148/radiol.2016151542 · Cited by 118 · see citing works
The impact of hepatitis C burden: an evidence‐based approach
Younossi, Z. M., Kanwal, F., Saab, S., Brown, K., El‐Serag, H. B., Kim, W. R., Ahmed, A., Kugelmas, M., & Gordon, S. C. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12625 · Cited by 116 · see citing works
The Burden of Cancer in Asian Americans: A Report of National Mortality Trends by Asian Ethnicity
Thompson, C. A., Gomez, S. L., Hastings, K. G., Kapphahn, K., Yu, P. P., Shariff‐Marco, S., Bhatt, A. S., Wakelee, H. A., Patel, M. I., Cullen, M. R., et al. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0167 · Cited by 114 · see citing works
Younossi, Z. M., Stepanova, M., Feld, J. J., Zeuzem, S., Jacobson, I. M., Agarwal, K., Hézode, C., Nader, F., Henry, L. L., & Hunt, S. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.042 · Cited by 109 · see citing works
Konerman, M. A., Thomson, M., Gray, K. E., Moore, M., Choxi, H., Seif, E. R., & Lok, A. S.-F. (2017) · Hepatology · doi:10.1002/hep.29362 · Cited by 109 · see citing works
“(4-6) Given that risk based screening had not adequately addressed this deficiency, the Centers for Disease Control and Prevention (CDC) and the United States Preventive Services Task Force (USPSTF) recommended one-time screening for all baby boomers (adults born between 1945 and 1965) regardless of the presence of an…”
Greenaway, C. A., Ma, A. T., Kloda, L. A., Klein, M. B., Cnossen, S., Schwarzer, G., & Shrier, I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141715 · Cited by 107 · see citing works
“Preventive Services Task Force (USPTF) recently recommended a one-time HCV birth cohort screening program (Baby Boomers born between 1945 and 1965) in addition to risk factor based screening programs [10, 12].”
MethodCuring Hepatitis C Virus Infection: Best Practices From the U.S. Department of Veterans Affairs
Belperio, P. S., Chartier, M., Ross, D. B., Alaigh, P., & Shulkin, D. J. (2017) · Annals of Internal Medicine · doi:10.7326/m17-1073 · Cited by 106 · see citing works
Byers, T., Wender, R. C., Jemal, A., Baskies, A. M., Ward, E. E., & Brawley, O. W. (2016) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21348 · Cited by 108 · see citing works
The oncologic burden of hepatitis C virus infection: A clinical perspective
Torres, H. A., Shigle, T. L., Hammoudi, N., Link, J. T., Samaniego, F., Kaseb, A. O., & Mallet, V. O. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21403 · Cited by 104 · see citing works
Molecular cancer prevention: Current status and future directions
Maresso, K. C., Tsai, K. Y., Brown, P. H., Szabo, E. M., Lippman, S. M., & Hawk, E. T. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21287 · Cited by 92 · see citing works
“In an attempt to minimize HBV/HCV-related adverse health effects broadly, including HCC development, the Centers for Disease Control and Prevention currently recommends viral screening in asymptomatic or healthy high-risk populations, including one-time HCV screening in adults who were born between 1945 and 1965.(296,…”
BackgroundManagement of acute HCV infection in the era of direct-acting antiviral therapy
Martinello, M., Hajarizadeh, B., Grebely, J., Dore, G. J., & Matthews, G. V. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0026-5 · Cited by 90 · see citing works
The new paradigm of hepatitis C therapy: integration of oral therapies into best practices
Afdhal, N. H., Zeuzem, S., Schooley, R. T., Thomas, D. L., Ward, J. W., Litwin, A. H., Razavi, H. A., Castéra, L., Poynard, T., Muir, A. J., et al. (2013) · Journal of Viral Hepatitis · doi:10.1111/jvh.12173 · Cited by 90 · see citing works
Ramsey, S. D., Unger, J. M., Baker, L. H., Little, R. F., Loomba, R. S., Hwang, J. P., Chugh, R. K., Konerman, M. A., Arnold, K. B., Menter, A. R., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.6437 · Cited by 88 · see citing works
Decreases in Hepatitis C Testing and Treatment During the COVID-19 Pandemic
Kaufman, H. W., Bull–Otterson, L., Meyer, W. A., Huang, X., Doshani, M., Thompson, W., Osinubi, A., Khan, M. A., Harris, A. M., Gupta, N., et al. (2021) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.03.011 · Cited by 88 · see citing works
Guirguis, J. K., Chhatwal, J., Dasarathy, J., Rivas, J. M., McMichael, D., Nagy, L. E., McCullough, A. J., & Dasarathy, S. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12887 · Cited by 86 · see citing works
Sullivan, P. S., Stephenson, R. B., Grazter, B., Wingood, G. M., DiClemente, R. J., Allen, S. A., Hoff, C. C., Salazar, L. F., Scales, L., Montgomery, J., et al. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-249 · Cited by 86 · see citing works
Assessing the cost-effectiveness of hepatitis C screening strategies in France
Deuffic‐Burban, S., Huneau, A., Verleene, A., Brouard, C., Pillonel, J., Strat, Y. L., Cossais, S., Roudot‐Thoraval, F., Canva, V., Mathurin, P., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.027 · Cited by 85 · see citing works
Confronting the Emerging Epidemic of HCV Infection Among Young Injection Drug Users
Valdiserri, R. O., Khalsa, J. H., Dan, C., Holmberg, S. D., Zibbell, J. E., Holtzman, D. J., Lubran, R., & Compton, W. M. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301812 · Cited by 83 · see citing works
Assoumou, S. A., Tasillo, A., Leff, J. A., Schackman, B. R., Drainoni, M., Horsburgh, C. R., Barry, M. A., Regis, C., Kim, A. Y., Marshall, A. D., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix798 · Cited by 78 · see citing works
Jacobs-Wingo, J. L., Espey, D. K., Groom, A. V., Phillips, L. E., & Haverkamp, D. S. (2016) · American Journal of Public Health · doi:10.2105/ajph.2015.303033 · Cited by 77 · see citing works
Prevalence of major risk factors and use of screening tests for cancer in the United States
Fedewa, S. A., Sauer, A. G., Siegel, R. L., & Jemal, A. (2015) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0134 · Cited by 77 · see citing works
Recommendations on hepatitis C screening for adults
Canadian Task Force on Preventive Health Care (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.161521 · Cited by 76 · see citing works
KASL clinical practice guidelines: management of hepatitis C
(2016) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2016.22.1.76 · Cited by 75 · see citing works
Prevalence of HIV Infection among U.S. Hodgkin Lymphoma Cases
Shiels, M. S., Koritzinsky, E. H., Clarke, C. A., Suneja, G., Morton, L. M., & Engels, E. A. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0865 · Cited by 73 · see citing works
White, D. A. E., Anderson, E. S., Pfeil, S. K., Trivedi, T. K., & Alter, H. (2015) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2015.06.023 · Cited by 72 · see citing works
Barocas, J. A., Tasillo, A., Yazdi, G. E., Wang, J., Vellozzi, C. J., Hariri, S., Isenhour, C. J., Randall, L. M., Ward, J. W., Mermin, J., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy098 · Cited by 70 · see citing works
Liu, S., Cipriano, L. E., Holodniy, M., & Goldhaber‐Fiebert, J. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058975 · Cited by 68 · see citing works
Screening for Hepatitis C Virus Infection in Adolescents and Adults
Chou, R., Dana, T., Fu, R., Zakher, B., Wagner, J., Ramirez, S., Grusing, S., & Jou, J. H. (2020) · JAMA · doi:10.1001/jama.2019.20788 · Cited by 67 · see citing works
Konerman, M. A., Zhang, Y., Zhu, J., Higgins, P., Lok, A. S.-F., & Waljee, A. K. (2015) · Hepatology · doi:10.1002/hep.27750 · Cited by 66 · see citing works
“The Centers for Disease Control and Prevention, the Institute of Medicine, and the United States Preventive Services Task Force have advocated for HCV screening as well as treatment as a means of disease prevention.(3-5) The high prevalence of CHC in the United States paired with the high cost of direct-acting antivir…”
Millman, A. J., Nelson, N. P., & Vellozzi, C. J. (2017) · Current Epidemiology Reports · doi:10.1007/s40471-017-0108-x · Cited by 66 · see citing works
Udompap, P., Mannalithara, A., Heo, N., Kim, D., & Kim, W. R. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.009 · Cited by 65 · see citing works
Global elimination of hepatitis C virus infection: Progresses and the remaining challenges
Taherkhani, R., & Farshadpour, F. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i33.1239 · Cited by 63 · see citing works
Smith, M. A., Regal, R. E., & Mohammad, R. A. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015610342 · Cited by 63 · see citing works
“Chronic hepatitis C virus (HCV) affects nearly 4 million Americans and is the leading cause of complications from chronic liver disease.(1,2) Treatment of chronic HCV has rapidly advanced over the past several years from the foundation of peginterferon and ribavirin.”
BackgroundHepatitis C Treatment and Barriers to Eradication
Konerman, M. A., & Lok, A. S.-F. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.50 · Cited by 63 · see citing works
“The Centers for Disease Control and Prevention and United States Preventive Services Task Force recommended that HCV screening should be expanded to all baby boomers, persons born between 1945 and 1965, regardless of the presence of any of the traditional risk factors for HCV, given the fivefold higher prevalence of H…”
BackgroundMomin, B. R., Pinheiro, P. S., Carreira, H., Li, C., & Weir, H. K. (2017) · Cancer · doi:10.1002/cncr.30820 · Cited by 63 · see citing works
“37 According to the National Academies of Science, Engineering, and Medicine, 38 limited public and provider awareness and limited public resource allocation are the primary underlying causes of high rates of chronic HBV and HCV infections in the United States.”
Schechter‐Perkins, E. M., Miller, N. S., Hall, J., Hartman, J. J., Dorfman, D. H., Andry, C., & Linas, B. P. (2018) · Academic Emergency Medicine · doi:10.1111/acem.13484 · Cited by 60 · see citing works
“Preventive Services Task Force (USPSTF), endorsed guidance for routine onetime HCV antibody (Ab) screening for any individual born 1945 to 1965 (the “birth cohort”), as well as continued targeted testing for drug users and others at high risk for HCV infection.(1,2) That guidance increased rates of testing among those…”
Bourgi, K., Brar, I., & Baker-Genaw, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161241 · Cited by 60 · see citing works
Torres, H. A., Chong, P. P., Lima, M. J. G. D., Friedman, M., Giralt, S. A., Hammond, S. P., Kiel, P. J., Masur, H., McDonald, G. B., Wingard, J. R., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.07.033 · Cited by 59 · see citing works
Jadoul, M. Y., Awan, A. A., Berenguer, M., Bruchfeld, A. N., Fabrizi, F., Goldberg, D. S., Jia, J., Kamar, N., Mohamed, R., Pessôa, M. G., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.07.013 · Cited by 62 · see citing works
Prevalence of occult hepatitis C infection in chronic hemodialysis and kidney transplant patients
Baid‐Agrawal, S., Schindler, R., Reinke, P., Staedtler, A., Rimpler, S., Malik, B., Frei, U. A., & Berg, T. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.012 · Cited by 55 · see citing works
“The diagnosis of HCV is made currently by detection of antiHCV (antibody against HCV) and HCV RNA in serum [2,3].”
Community-based HCV screening: knowledge and attitudes in a high risk urban population
Norton, B. L., Voils, C. I., Timberlake, S. H., Hecker, E. J., Goswami, N. D., Huffman, K. M., Landgraf, A., Naggie, S., & Stout, J. E. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-74 · Cited by 55 · see citing works
“Discussion In an attempt to curtail the rising morbidity and mortality from undiagnosed HCV, the CDC and USPSTF have expanded screening guidelines to high-risk individuals and persons born 1945-1965 [9-11].”
BackgroundHepatitis C Virus in Women of Childbearing Age, Pregnant Women, and Children
Schillie, S. F., Canary, L., Koneru, A., Nelson, N. P., Tanico, W., Kaufman, H. W., Hariri, S., & Vellozzi, C. J. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.05.029 · Cited by 54 · see citing works
Is widespread screening for hepatitis C justified?
Koretz, R. L., Lin, K., Ioannidis, J. P. A., & Lenzer, J. (2015) · BMJ · doi:10.1136/bmj.g7809 · Cited by 52 · see citing works
Recent Hepatitis C Virus Testing Patterns Among Baby Boomers
Jemal, A., & Fedewa, S. A. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.01.033 · Cited by 51 · see citing works
Thomson, M., Konerman, M. A., Choxi, H., & Lok, A. S.-F. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4097-2 · Cited by 50 · see citing works
“Specifically, 19 % of PCPs failed to identify baby boomers as a higher risk population despite CDC and USPSTF recommendations [5, 6].”
BackgroundMethodContinuum of Care for Hepatitis C Virus Among Patients Diagnosed in the Emergency Department Setting
Anderson, E. S., Galbraith, J. W., Deering, L. J., Pfeil, S. K., Todorovic, T., Rodgers, J. B., Forsythe, J. M., Franco, R., Wang, H. E., Wang, N. E., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix163 · Cited by 50 · see citing works
Krans, E. E., Zickmund, S. L., Rustgi, V. K., Park, S. Y., Dunn, S. L., & Schwarz, E. B. (2015) · Substance Abuse · doi:10.1080/08897077.2015.1118720 · Cited by 49 · see citing works
Results of Hepatitis C Birth-Cohort Testing and Linkage to Care in Selected U.S. Sites, 2012–2014
Patel, R. C., Vellozzi, C. J., & Smith, B. D. (2016) · Public Health Reports · doi:10.1177/00333549161310s203 · Cited by 48 · see citing works
Schackman, B. R., Leff, J. A., Barter, D. M., DiLorenzo, M. A., Feaster, D. J., Metsch, L. R., Freedberg, K. A., & Linas, B. P. (2014) · Addiction · doi:10.1111/add.12754 · Cited by 47 · see citing works
Dibba, P., Cholankeril, R. T., Li, A. A., Patel, M., Fayek, M., Dibble, C. L., Okpara, N., Hines, A., & Ahmed, A. (2018) · Diseases · doi:10.3390/diseases6020031 · Cited by 47 · see citing works
Fontan Liver Disease: Review of an Emerging Epidemic and Management Options
Bradley, E. A., Hendrickson, B., & Daniels, C. J. (2015) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-015-0412-z · Cited by 45 · see citing works
Turner, B. J., Taylor, B. S., Hanson, J. T., Perez, M. E., Hernández, L., Villarreal, R. E., Veerapaneni, P., & Fiebelkorn, K. R. (2015) · Journal of Hospital Medicine · doi:10.1002/jhm.2376 · Cited by 44 · see citing works
Diagnosis and Management of Hepatitis C
Wilkins, T., Akhtar, M., Gititu, E., Jalluri, C., & Ramirez, J. (2024) · Journal of Correctional Health Care · doi:10.1089/jchc.2024.98233.cli · Cited by 44 · see citing works
Is global elimination of HCV realistic?
Calvaruso, V., Petta, S., & Craxı̀, A. (2018) · Liver International · doi:10.1111/liv.13668 · Cited by 44 · see citing works
Smith, B. D., Beckett, G. A., Yartel, A. K., Holtzman, D. J., Patel, N., & Ward, J. W. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301549 · Cited by 43 · see citing works
Turner, B. J., Taylor, B. S., Hanson, J. T., Liang, Y., Veerapaneni, P., Villarreal, R. E., Perez, M. E., Hernández, L., Sandhu, J., & Fiebelkorn, K. R. (2015) · Hepatology · doi:10.1002/hep.28018 · Cited by 42 · see citing works
Castrejón, M., Chew, K. W., Javanbakht, M., Humphries, R. M., Saab, S., & Klausner, J. D. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx109 · Cited by 42 · see citing works
Lima, V. D., Rozada, I., Grebely, J., Hull, M., Lourenço, L., Nosyk, B., Krajden, M., Yoshida, E. M., Wood, E., & Montaner, J. S. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143836 · Cited by 41 · see citing works
“One critical aspect for the success of the proposed interventions is to identify and test individuals unaware that they are HCV-positive [38, 39].”
BackgroundAccess to treatment for hepatitis C virus infection: time to put patients first
Edlin, B. R. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30005-6 · Cited by 41 · see citing works
Predictors of linkage to care for a nontargeted emergency department hepatitis C screening program
Blackwell, J. A., Rodgers, J. B., Franco, R., Cofield, S. S., Walter, L. A., Galbraith, J. W., & Hess, E. P. (2019) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.11.034 · Cited by 41 · see citing works
“were born between 1945 and 1965, the Centers for Disease Control and Prevention (CDC) and United States Preventive Services Task Force (USPSTF) issued recommendations in 2012 that all baby boomers receive routine, one-time HCV testing [6, 7].”
BackgroundChronic Viral Hepatitis: Current Management and Future Directions
Do, A., & Reau, N. S. (2020) · Hepatology Communications · doi:10.1002/hep4.1480 · Cited by 41 · see citing works
Management of hepatitis C in patients with chronic kidney disease
de Carvalho‐Filho, R. J. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i2.408 · Cited by 40 · see citing works
Barocas, J. A., Wang, J., White, L. F., Tasillo, A., Salomon, J. A., Freedberg, K. A., & Linas, B. P. (2017) · Health Affairs · doi:10.1377/hlthaff.2017.0684 · Cited by 39 · see citing works
Global epidemiology of viral hepatitis and national needs for complete control
Lanini, S., Pisapia, R., Capobianchi, M. R., & Ippolito, G. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1505503 · Cited by 39 · see citing works
Opioid epidemic and liver disease
Verna, E. C., Schluger, A., & Brown, R. S. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.06.006 · Cited by 40 · see citing works
Can hepatitis C be eradicated in the United States?
Edlin, B. R., & Winkelstein, E. R. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.07.015 · Cited by 38 · see citing works
KASL clinical practice guidelines: Management of Hepatitis C
(2014) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2014.20.2.89 · Cited by 37 · see citing works
Zou, B., Yeo, Y. H., Le, M. H., Henry, L. L., Chang, E. T., Lok, A. S.-F., Cheung, R. C., & Nguyen, M. H. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz479 · Cited by 37 · see citing works
Mehta, S. J., Torgersen, J., Small, D. S., Mallozzi, C. P., McGreevey, J. D., Rareshide, C. A. L., Evans, C. N., Epps, M., Stabile, D., Snider, C. K., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.2427 · Cited by 39 · see citing works
- Authors
- Moyer, V. A.
- Affiliations
- United States Preventive Services Task Force (US)
- Corresponding author
- Moyer, Virginia A.
- ORCID
- Moyer, Virginia A.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2013-09
- Volume
- 159
- Issue
- 5
- Pages
- 349-357
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2148959572
- Cited by
- 475
- References
- 18
- Citations by year
- 2026: 2 · 2025: 11 · 2024: 5 · 2023: 8 · 2022: 21 · 2021: 23 · 2020: 40 · 2019: 50 · 2018: 59 · 2017: 57 · 2016: 68 · 2015: 59 · 2014: 52 · 2013: 19
- FWCI
- 41.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Keywords
- hepatitis C virus, HCV screening, asymptomatic adults, vulnerable populations, hepatitis C treatment, baby boomers, screening guidelines
- MeSH terms
- Adult, Age Factors, Antiviral Agents, Female, Humans, Mass Screening, Pregnancy, Pregnancy Complications, Infectious, Cost of Illness, Risk Assessment, Hepatitis C, Chronic, Early Diagnosis, Asymptomatic Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
